TABLE 2.
Methodological quality of included studies in accordance with the PEDro scores.
| Study | 1* | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Total |
| Naro et al., 2021 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6/10 | ||||
| Picelli et al., 2018 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 9/10 | |
| Picelli et al., 2015 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 9/10 | |
| Geroin et al., 2011 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 8/10 | ||
| Madhavan et al., 2020 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 9/10 | |
| Manji et al., 2018 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 8/10 | ||
| Seo et al., 2017 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 9/10 | |
| Leon et al., 2017 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6/10 | ||||
| Mitsutake et al., 2021 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 8/10 |
*Not included in the total score. PEDro scores: 1, eligibility criteria specified; 2, participants randomly allocated to groups; 3, allocation concealed; 4, groups similar at baseline; 5, participants were blinded; 6, therapists were blinded; 7, assessors were blinded; 8, data available for more than 85% of participants; 9, participants received the treatment as allocated or intention-to-treat analysis was used; 10, statistical analyses were reported; 11, point measures and variability measures of data reported.